Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden.
Vox Sang. 2014 Oct;107(3):205-12. doi: 10.1111/vox.12172. Epub 2014 Jun 27.
Present platelet storage media often designated platelet additive solutions (PAS) basically contain acetate, citrate and phosphate and recently also potassium and magnesium. However, there seems to be an increasing interest in developing PASs that can be used also after further reduction of residual plasma content below 15-20% plasma. Inclusion of glucose but also calcium and bicarbonate in such solutions have been suggested to improve platelet (PLT) storage, especially when plasma content is reduced to very low levels. Results from a limited number of studies using novel PAS alternatives have been presented during the last years, such as InterSol-G, PAS-5, M-sol, PAS-G and SAS. Most of them are experimental solutions. The combined results presented in those studies suggest that presence of glucose may be necessary during PLT storage, primarily to maintain ATP at acceptable levels. At plasma inclusion below 15-20%, the content of glucose will generally be too low to support PLT metabolism for more than a few days making glucose addition in PAS necessary. Significant effects associated with presence of calcium was observed in PLTs stored in PAS with 5% inclusion but not with 20-35% plasma inclusion, suggesting that the content of plasma could be of importance. Bicarbonate only seems to be of importance for pH regulation, primarily when plasma inclusion is reduced to about 5%. Reduction in rate of glycolysis was observed in some PAS alternatives containing potassium and magnesium but not in others. Differences in pH or in concentrations of the various compounds included in PAS may be possible explanations. Additionally, novel PAS containing glucose, calcium and bicarbonate does not seem to be associated with improved in vitro results as compared to SSP+ or CompoSol when PLTs are stored with 35% plasma inclusion. The results would then also suggest that excess of glucose in novel PAS environment may not be associated with additional positive effects on PLT metabolism. This review is based on the few publications on novel PAS available, and additional studies would be needed in the future.
目前的血小板储存介质通常被指定为血小板添加剂溶液(PAS),主要包含醋酸盐、柠檬酸盐和磷酸盐,最近还包括钾盐和镁盐。然而,人们似乎越来越有兴趣开发 PAS,使其在进一步降低残留血浆含量至 15-20%以下时也能使用。在这种溶液中加入葡萄糖以及钙和碳酸氢盐被认为可以改善血小板(PLT)的储存,尤其是当血浆含量降低到非常低的水平时。在过去的几年中,已经提出了一些使用新型 PAS 替代品的有限研究的结果,例如 InterSol-G、PAS-5、M-sol、PAS-G 和 SAS。它们大多数是实验性溶液。这些研究中提出的综合结果表明,在 PLT 储存期间,葡萄糖的存在可能是必要的,主要是为了维持 ATP 处于可接受的水平。当血浆含量低于 15-20%时,葡萄糖的含量通常太低,无法支持 PLT 代谢超过几天,因此需要在 PAS 中添加葡萄糖。在 PAS 中加入 5%的血浆含量时观察到与钙存在相关的显著效果,但在加入 20-35%的血浆含量时则没有观察到,这表明血浆含量可能很重要。碳酸氢盐似乎仅对 pH 调节很重要,主要是当血浆含量降低至约 5%时。在一些含有钾和镁的 PAS 替代品中观察到糖酵解速率降低,但在其他替代品中则没有。PAS 中包含的各种化合物的 pH 或浓度的差异可能是可能的解释。此外,与 SSP+或 CompoSol 相比,当使用 35%的血浆含量储存 PLT 时,含有葡萄糖、钙和碳酸氢盐的新型 PAS 似乎并没有改善体外结果。这些结果还表明,新型 PAS 环境中过量的葡萄糖可能不会对 PLT 代谢产生额外的积极影响。这篇综述基于现有的少数关于新型 PAS 的出版物,未来还需要进行更多的研究。